It works by binding to the ghrelin receptor (GHS-R1a) , stimulating the release of: Growth Hormone (GH) Insulin-Like Growth Factor 1 (IGF-1) Unlike injectable peptides, MK-677 is often studied for its long-lasting systemic activity , making it distinct in research comparing GH pathway compounds
PMID 17991639
Importantly, AKT1-WT, but not AKT1-3K/R, in shAKT1 breast tumors displayed comparable levels of p-AKT1 (T308) and p-AKT1 (S473) to those observed in shSC control tumors (Fig
This is to be expected, as there are many different versions of the research peptide on the market: CJC-1295 DAC CJC-1295 No DAC CJC-1295 + Ipamorelin To that end, we summarize the main research findings regarding CJC-1295 side effects, and outline what researchers must know when investigating this growth hormone-releasing hormone analog
Intramuscular or Intravenous injection
If this does not appeal to you, then transplant surgery may still be viable